|Bid||0.00 x 800|
|Ask||0.00 x 1000|
|Day's range||207.67 - 210.26|
|52-week range||200.47 - 276.69|
|Beta (5Y monthly)||0.68|
|PE ratio (TTM)||21.20|
|Earnings date||02 Nov 2021|
|Forward dividend & yield||7.04 (3.37%)|
|Ex-dividend date||16 Aug 2021|
|1y target est||247.45|
In the latest trading session, Amgen (AMGN) closed at $206.78, marking a +1.8% move from the previous day.
These dividend stocks provide sustainable and growing dividends, which are nearly triple the S&P 500's yield.
Amgen (AMGN) reports new combination data from the phase Ib CodeBreaK 101 study. It also buys a stake in Neumora Therapeutics to advance novel therapies for brain diseases.